case managment/ AUC etc Flashcards

1
Q

what is the dose of IV epi for severe analylaxis

What is pre med dosages

do you need to treat for shellfish allerg

A

IV 1:10K over 5-15 min

prod 50 x 3 over 24 hours planned for emergent pred 50 IV x 1 or hydrocort 200 mg daily

dont need to

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the treaments for severe reactions.?

A

Laryengeal edema SQ 1:1000, benadyl, hydrochort 200 mg

Hypotension

  • IVF
  • 1:10K IVP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

IV enox dose for PCI if have been given a dose

A

0.3 mg/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

SOHD when can you revasc

a. for sx -
b. for px - LM, LAD , 2VD or 3VD, LV dysfunction with ischemia or FFR < 0.80 for any lad

A

a. Stenosis > 50% with limiting anging
- sten > 50% with dyspnea or CHF and > 10% LV ischemia
- no limiting sx on OMT
b. for px
- LM > 50%
- any LAD > 50% with documented ischemia or FFR < 0.80
- 2VD or 3VD , LV dysfuntion with ischemia or FFR < 0.80
- large are of ischemia,
- )dont do pci for 1 VD not lad and no ischemia doc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SIHD important class three for PCI

A

no ischemia documented non LAD vessel with single vessel dz

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PCI vs. CABG Guidelines

A

Can do CABG for all lesional varietes except 1vd/ 2vd no prox lad. (when should do PCI.

Should not do pci Class III 3VD syntax > 22 and ful revasc not possible.

LM + 2VD or 3VD with syntax >= 33

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

synatx need to now for AUC (2)

A

> 22 and 3vd/2vd and full revasc not possilbe

>= 33 and LM + 2v or 3vd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do the guidelines consider PCI

A

reduces incidence of angina, may increase risk of short term MI and doesnt lower the long term risk of MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

5 year syntax

A

no differnce in mort but higher mace due to higher revasc.

-<=22 no difference also lm.

22-32 3V subgroup does diverge but LM doesnt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

dm pci vs cabg

A

maace higher with pci 46b vs 29 p 0.0002

freedom 1900 18.7 vs 26.6 exception of stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Syntax 2 interesting finding

A

women did better with cabg than pci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CABG for survival

A

LM >50%

3VD

CABG or PCI VT due to ischemia mediated VT

lima to pLAD (single vessel dz)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Syntax II what factors lowered syntax for CABG

A

female, younger, LVEF reduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

LM PCI two major studyies

A

Nobel included repeat pci at 5 years no mor difference, older stent types.

Excel (xience) –> awaiting 5 year

Syntax LM no difference TVR high PCI and stroke higher for cabg (same theme)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

general theme of all PCI vs. CABG studies

A

no diff in mort, higher macce driven by TLR, higher stroe with cabg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What did stitches show?

A

improved survival at ten years post CABG compared to medical therapy alone. EF < 35% no need for viability

17
Q

Drachmans 7 px reason for revasc with PCI - first four aare antaomic

A
  1. LM
  2. pLAD
  3. multivessel dz
  4. LV dysfunction
  5. large ischemic burden
  6. ischemic VT/cardiac arrest
  7. acs CV shoc
18
Q

Guidleine genral concepts: Revasc vs. med therapy for SIHD

A

for those with silent ischemia or mild sx only revasc if adverse events –> VT, EF drop, MI

19
Q

When need a cath after noninvasive testing 4

A

resting or exercise induced lv dysfucntion, stress echo +

duke treadmill score greater than negative 11

LV dilitation or lung uptae with perfusion imaging

CAC >400 agaston

20
Q

CAC score in which recommend revasc?

A

> 400 agaston units

21
Q

revasc is most beneficial with what degree of ischmia?

A

> 10% per GL (not really in AUC interesting), in one study really was 20% (death 7% vs. 2%)

22
Q

courage trial basic facts

when did it end?

A

2004

inclusion angina or + NST and CAD on cath

2287 (1149 PCI + OMT and 1138 OMT)

follow up median 4.6 years

23
Q

Biggest issue with courage

A

crossover of 32%

also pci was not ischemia driven

PCI success 93%

24
Q

BARI 2 D study

inclusion

results

A

inclusion - DM and 50% >= stnnosis without prior intervention 2x2 factial

did not compare PCI to cabg, CABG vs. OMT and PCI and OMT

reduction of advers events with CABG revasc.

revasc did reduce angina

25
Q

fame 1005 patients FFR

A

FFR guided approach reduction in MACE (driven by revasc)

26
Q

Fame II

A

FFR PCI + OMT vs. OMT in stable CAD

27
Q

fame II 5 year

A

reduced death or mi at 5 years

28
Q

NSTEMI early invasive how early

A

2 hours if ongoing angina, hemodynamic stability, ischemia at rest or VT

24 hours otherwise–> in general iia

29
Q
A